NCT04087707

Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects

A Clinical Pharmacological Study of TS-142 in Non-Elderly and Elderly Healthy Participants (A Repeated-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Elderly and Non-Elderly Participants)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Taisho Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the safety, pharmacokinetics, and pharmacodynamics of repeated dosing of TS-142 when administered once daily to healthy Japanese non-elderly and elderly participants

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	Step 1: TS-142	Non-elderly participants will receive 20 mg of TS-142 once daily for 7 consective days
DRUG	Step 2: TS-142	Elderly participants will receive 20 mg of TS-142 once daily for 7 consective days
DRUG	Step 2: Placebo	Elderly participants will receive placebo once daily for 7 consective days

Timeline

• Start date: 2019-09-17
• Primary completion: 2019-11-30
• Completion: 2019-11-30
• First posted: 2019-09-12
• Last updated: 2025-02-28

Locations

1 site across 1 country: Japan